Insider Buy/Sell Details for the Healthcare Sector — Last 3 Months
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (5295)
Omada Health, Inc. (OMDA)
Gracey Craig — Chief Accounting Officer
Shares
644
Price
$21.73
Total Value
$14.00K
Shares Held After
14,412
% of Holdings
4.3%
VEEVA SYSTEMS INC (VEEV)
Hung Priscilla — Director
Shares
750
Price
$261.04
Total Value
$195.78K
Shares Held After
3,242
% of Holdings
18.8%
NovaBridge Biosciences (NBP)
Cao Sean Wuxiong — Chief Bus. Development Officer
Shares
107,978
Price
$0.74
Total Value
$79.90K
Shares Held After
266,467
% of Holdings
28.8%
Tyra Biosciences, Inc. (TYRA)
Verjee Rehan — Director
Shares
972
Price
$20.58
Total Value
$20.00K
Shares Held After
972
% of Holdings
100.0%
INSMED Inc (INSM)
Brennan David R — Director
Shares
25,000
Price
$124.00
Total Value
$3.10M
Shares Held After
39,238
% of Holdings
38.9%
Tenon Medical, Inc. (TNON)
HRT FINANCIAL LP — 10% Owner
Shares
9,948
Price
$4.27
Total Value
$42.48K
Shares Held After
18,182
% of Holdings
35.4%
Tenon Medical, Inc. (TNON)
HRT FINANCIAL LP — 10% Owner
Shares
39,508
Price
$3.40
Total Value
$134.33K
Shares Held After
18,182
% of Holdings
217.3%
Tenon Medical, Inc. (TNON)
HRT FINANCIAL LP — 10% Owner
Shares
50,395
Price
$2.61
Total Value
$131.53K
Shares Held After
18,182
% of Holdings
73.5%
Pharvaris N.V. (PHVS)
Glassman Robert — Director
Shares
8,000
Price
$37.55
Total Value
$300.40K
Shares Held After
10,500
% of Holdings
43.2%
KAMADA LTD (KMDA)
Tsur David — Director
Shares
175
Price
$8.26
Total Value
$1.45K
Shares Held After
430,756
% of Holdings
0.0%
Aquestive Therapeutics, Inc. (AQST)
Korczynski Sherry — Chief Commercial Officer
Shares
8,750
Price
$5.22
Total Value
$45.67K
Shares Held After
235,689
% of Holdings
3.6%
RELMADA THERAPEUTICS, INC. (RLMD)
TRAVERSA SERGIO — Director
Shares
100,000
Price
$4.18
Total Value
$418.00K
Shares Held After
1,400,000
% of Holdings
7.1%
RELMADA THERAPEUTICS, INC. (RLMD)
Shenouda Maged — Chief Financial Officer
Shares
120,200
Price
$4.20
Total Value
$504.84K
Shares Held After
920,200
% of Holdings
13.1%
Protagonist Therapeutics, Inc (PTGX)
PATEL DINESH V PH D — Director
Shares
63,548
Price
$146.18
Total Value
$9.29M
Shares Held After
522,968
% of Holdings
10.8%
PRO DEX INC (PDEX)
Van Kirk Richard Lee Jr — Director
Shares
4,768
Price
$59.45
Total Value
$283.46K
Shares Held After
79,993
% of Holdings
5.6%
PRO DEX INC (PDEX)
Van Kirk Richard Lee Jr — Director
Shares
806
Price
$58.66
Total Value
$47.28K
Shares Held After
84,761
% of Holdings
0.9%
PRO DEX INC (PDEX)
Van Kirk Richard Lee Jr — Director
Shares
300
Price
$64.70
Total Value
$19.41K
Shares Held After
85,567
% of Holdings
0.3%
PRO DEX INC (PDEX)
Van Kirk Richard Lee Jr — Director
Shares
2,144
Price
$63.85
Total Value
$136.89K
Shares Held After
85,867
% of Holdings
2.4%
PRO DEX INC (PDEX)
Van Kirk Richard Lee Jr — Director
Shares
935
Price
$62.93
Total Value
$58.84K
Shares Held After
88,011
% of Holdings
1.1%
PRO DEX INC (PDEX)
Van Kirk Richard Lee Jr — Director
Shares
1,157
Price
$61.88
Total Value
$71.60K
Shares Held After
88,946
% of Holdings
1.3%
PRO DEX INC (PDEX)
Van Kirk Richard Lee Jr — Director
Shares
4,274
Price
$60.72
Total Value
$259.52K
Shares Held After
90,103
% of Holdings
4.5%
PRO DEX INC (PDEX)
Van Kirk Richard Lee Jr — Director
Shares
2,691
Price
$59.84
Total Value
$161.03K
Shares Held After
94,377
% of Holdings
2.8%
PRO DEX INC (PDEX)
Van Kirk Richard Lee Jr — Director
Shares
2,160
Price
$58.92
Total Value
$127.27K
Shares Held After
97,068
% of Holdings
2.2%
PRO DEX INC (PDEX)
Charlton Alisha — Chief Financial Officer
Shares
800
Price
$61.76
Total Value
$49.41K
Shares Held After
21,870
% of Holdings
3.5%
PRO DEX INC (PDEX)
Charlton Alisha — Chief Financial Officer
Shares
1,500
Price
$61.05
Total Value
$91.58K
Shares Held After
22,670
% of Holdings
6.2%
NEUROCRINE BIOSCIENCES INC (NBIX)
BENEVICH ERIC — Chief Commercial Officer
Shares
2,154
Price
$154.61
Total Value
$333.03K
Shares Held After
64,408
% of Holdings
3.2%
Inhibrx Biosciences, Inc. (INBX)
MANHARD KIMBERLY — Director
Shares
500
Price
$115.80
Total Value
$57.90K
Shares Held After
9,000
% of Holdings
5.3%
PROCEPT BioRobotics Corp (PRCT)
Templin Barry L — EVP, Chief Technology Officer
Shares
373
Price
$20.95
Total Value
$7.82K
Shares Held After
94,826
% of Holdings
0.4%
PROCEPT BioRobotics Corp (PRCT)
Nouri Alaleh — EVP, CLO, CORP. SEC.
Shares
297
Price
$20.95
Total Value
$6.22K
Shares Held After
127,737
% of Holdings
0.2%
PROCEPT BioRobotics Corp (PRCT)
Waters Kevin — EVP, CFO
Shares
373
Price
$20.95
Total Value
$7.82K
Shares Held After
180,355
% of Holdings
0.2%
Fortrea Holdings Inc. (FTRE)
Russell Carrie Elizabeth — Interim CAO
Shares
246
Price
$16.85
Total Value
$4.15K
Shares Held After
2,384
% of Holdings
9.4%
Beta Bionics, Inc. (BBNX)
Hopman Mark — Chief Commercial Officer
Shares
36,870
Price
$18.46
Total Value
$680.72K
Shares Held After
87,157
% of Holdings
29.7%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
200
Price
$509.00
Total Value
$101.80K
Shares Held After
324,443
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
506
Price
$507.68
Total Value
$256.88K
Shares Held After
324,643
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
794
Price
$506.84
Total Value
$402.43K
Shares Held After
325,149
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
875
Price
$505.78
Total Value
$442.56K
Shares Held After
325,943
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
964
Price
$505.03
Total Value
$486.85K
Shares Held After
326,818
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,144
Price
$503.60
Total Value
$576.12K
Shares Held After
327,782
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,017
Price
$502.87
Total Value
$511.41K
Shares Held After
328,926
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
361
Price
$500.84
Total Value
$180.80K
Shares Held After
329,943
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
519
Price
$499.73
Total Value
$259.36K
Shares Held After
330,304
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
400
Price
$498.85
Total Value
$199.54K
Shares Held After
330,823
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
160
Price
$497.56
Total Value
$79.61K
Shares Held After
331,223
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,278
Price
$496.73
Total Value
$634.82K
Shares Held After
331,383
% of Holdings
0.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,202
Price
$495.65
Total Value
$595.77K
Shares Held After
332,661
% of Holdings
0.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
80
Price
$493.81
Total Value
$39.50K
Shares Held After
333,863
% of Holdings
0.0%
BRISTOL MYERS SQUIBB CO (BMY)
Massacesi Cristian — EVP,Chief Med Offr,Head of Dev
Shares
6,249
Price
$64.57
Total Value
$403.50K
Shares Held After
18,748
% of Holdings
25.0%
YD Bio Ltd (YDES)
Shen Ethan PhD — Director
Shares
3,100
Price
$3.93
Total Value
$12.18K
Shares Held After
11,245,631
% of Holdings
0.0%
Korro Bio, Inc. (KRRO)
Dolan Oliver — Senior Vice President, Finance
Shares
6
Price
$13.60
Total Value
$81.62
Shares Held After
16,246
% of Holdings
0.0%
Fortrea Holdings Inc. (FTRE)
Morais Mark A. — Chief Operating Officer
Shares
3,149
Price
$16.85
Total Value
$53.06K
Shares Held After
81,794
% of Holdings
3.7%
Showing 1301–1350 of 5295 transactions (page 27 of 106)